CAIV-T vaccine: Phase III data

In a double-blind, placebo-controlled, international Phase III trial in 8,475 children aged 6-59 months, there were 54.9% fewer cases of

Read the full 209 word article

How to gain access

Continue reading with a
two-week free trial.